Archive

Rapid high-dose buprenorphine treatment strategy reduces opioid withdrawal in individuals using fentanyl

Written by | 9 Nov 2023

Buprenorphine is a medication approved for pain and opioid dependence. New findings published in The American Journal on Addictions indicate that a transmucosal dose (which dissolves in the mouth) of […]

UK researchers lead study identifying varied factors in buprenorphine users and urine drug testing

Written by | 5 Nov 2023

A study by a team of researchers across the country, including two from the University of Kentucky, is the first to demonstrate a connection between the characteristics of […]

Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder

Written by | 24 Sep 2023

Individuals with opioid use disorder who were prescribed a lower buprenorphine dose were 20% more likely to discontinue treatment than those on a higher dose, according to a […]

Easier access to opioid painkillers may reduce opioid-related deaths

Written by | 3 Jul 2023

Increasing access to prescription opioid painkillers may reduce opioid overdose deaths in the United States, according to a Rutgers study. “When access to prescription opioids is heavily restricted, […]

Overdose deaths involving buprenorphine did not proportionally increase with new flexibilities in prescribing

Written by | 25 Jan 2023

The proportion of opioid overdose deaths involving buprenorphine, a medication used to treat opioid use disorder, did not increase in the months after prescribing flexibilities were put in […]

Pharmacists can start patients on road to recovery from opioid use disorder

Written by | 14 Jan 2023

A study from researchers at Brown University, Rhode Island Hospital and the University of Rhode Island found that pharmacists — not just physicians at clinics and doctor’s offices […]

Half of patients in telemedicine program for opioid use disorder current with medication a month later

Written by | 25 Nov 2022

More than half of the patients who were prescribed medication to treat opioid use disorder through a virtual program established during the pandemic continued with their treatment at […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.